New research shows the ongoing effects from critical illness with COVID-19 can be long and serious.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Critically ill patients from intensive care units are part of a global trial testing a suite of flu and pneumonia drugs in a bid to combat COVID-19.
The public's panic surrounding COVID-19 is understandable given the steep decline in trust of authorities.
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Dummy text
